Request Demo
Last update 11 Jan 2025
Shanghai JMT Biological Technology Co Ltd
Last update 11 Jan 2025
Overview
Tags
Neoplasms
Respiratory Diseases
Skin and Musculoskeletal Diseases
Monoclonal antibody
Bispecific antibody
Antibody fusion proteins
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20244675
KN026联合HB1801对比曲妥珠单抗联合帕妥珠单抗和多西他赛新辅助治疗早期或局部晚期HER2阳性乳腺癌的有效性和安全性的随机、对照、开放、多中心、Ⅲ期临床研究
[Translation] A randomized, controlled, open, multicenter, phase III clinical study comparing the efficacy and safety of KN026 combined with HB1801 in neoadjuvant treatment of early or locally advanced HER2-positive breast cancer with trastuzumab combined with pertuzumab and docetaxel
NCT06747338
A Randomized, Controlled, Open-label, Multicenter, Phase III Clinical Trial to Compare the Efficacy and Safety of KN026 Combined With HB1801 Versus Trastuzumab Combined With Pertuzumab and Docetaxel in Neoadjuvant Treatment of Early or Locally Advanced HER2-positive Breast Cancer.
CTR20243768
评价JMT601联合不同化疗方案治疗CD20阳性弥漫性大B细胞淋巴瘤参与者的有效性和安全性的多中心、Ⅱ期临床研究
[Translation] A multicenter, phase II clinical study to evaluate the efficacy and safety of JMT601 combined with different chemotherapy regimens in the treatment of participants with CD20-positive diffuse large B-cell lymphoma
100 Clinical Results associated with Shanghai JMT Biological Technology Co Ltd
Login to view more data
Login to view more data
100 Deals associated with Shanghai JMT Biological Technology Co Ltd
Login to view more data
100 Translational Medicine associated with Shanghai JMT Biological Technology Co Ltd
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 21 Jan 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
2
IND Application
Phase 1
2
2
Phase 2
Phase 3
3
1
Approved
Other
2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free